-
-
-
-
-
-
-
United Therapeutics Announces $250 Million Share Repurchase Program
-
-
-
-
-
-
-
Canaccord Genuity Maintains a 'Hold' on United Therapeutics (UTHR); Increasing FY12 Adcirca and Tyvaso Revenues
-
-
77,549 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All